These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29536088)

  • 1. Frequency and Magnitude of Co-payments Exceeding Prescription Drug Costs.
    Van Nuys K; Joyce G; Ribero R; Goldman DP
    JAMA; 2018 Mar; 319(10):1045-1047. PubMed ID: 29536088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare prescription drug plan costs and affordability--2007.
    Davis MM
    J Gen Intern Med; 2007 Aug; 22(8):1221-2. PubMed ID: 17497191
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incentive-based formularies.
    Thomas CP
    N Engl J Med; 2003 Dec; 349(23):2186-8. PubMed ID: 14657424
    [No Abstract]   [Full Text] [Related]  

  • 5. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gap in drug coverage often causes lapses in adherence to drug regimen, study shows.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):9-10, 12. PubMed ID: 15452947
    [No Abstract]   [Full Text] [Related]  

  • 8. What Determines How Much Your Patient Pays for Their Medication in the United States?
    Novack GD
    Am J Ophthalmol; 2016 Jul; 167():48-51. PubMed ID: 27131775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial consequences of drug benefit plans.
    Motheral B; Sheth J
    JAMA; 2003 Jan 22-29; 289(4):423-4; author reply 424. PubMed ID: 12533119
    [No Abstract]   [Full Text] [Related]  

  • 10. Financial consequences of drug benefit plans.
    Hsu J; Reed M
    JAMA; 2003 Jan 22-29; 289(4):423; author reply 424. PubMed ID: 12533118
    [No Abstract]   [Full Text] [Related]  

  • 11. Financial consequences of drug benefit plans.
    Clark BE; Garis RI
    JAMA; 2003 Jan 22-29; 289(4):423; author reply 424. PubMed ID: 12533117
    [No Abstract]   [Full Text] [Related]  

  • 12. Plastic price cuts? Drug discount cards shave but don't slash high bills. And most aren't free.
    Comarow A
    US News World Rep; 2002 Apr; 132(12):74-6. PubMed ID: 11974551
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of drug regimen costs between the Medicare prescription discount program and other purchasing systems.
    Hayes JM; Walczak H; Prochazka A
    JAMA; 2005 Jul; 294(4):427-8. PubMed ID: 16046648
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling spending for prescription drugs.
    Altman SH; Parks-Thomas C
    N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of incentive-based formularies on drug utilization and spending.
    Sandy LG; Heady T
    N Engl J Med; 2004 Mar; 350(10):1057. PubMed ID: 15002122
    [No Abstract]   [Full Text] [Related]  

  • 17. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of incentive-based formularies on drug utilization and spending.
    Shrank WH
    N Engl J Med; 2004 Mar; 350(10):1057. PubMed ID: 14999122
    [No Abstract]   [Full Text] [Related]  

  • 19. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
    Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.